Ventriculomegaly and Gait Disturbance in the Senior Population in the Region of Västerbotten
NCT ID: NCT05204745
Last Updated: 2022-01-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
6500 participants
OBSERVATIONAL
2018-02-14
2021-12-22
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Vascular Risk Factors in INPH-patients
NCT01850914
Gait Pattern and Experienced Global Change After Shunt Surgery in Idiopathic Normal Pressure Hydrocephalus
NCT04795089
Idiopathic Normal Pressure Hydrocephalus: Focus on Imaging and Clinical Symptoms.
NCT04808076
Computerized Neuropsychology in Idiopathic Normal Pressure Hydrocephalus (INPH)
NCT01265251
Clinical Outcome in Patients With INPH
NCT06428734
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Case
Subjects with subjective gait impariment according to questionnaire answers.
No interventions assigned to this group
Control
Subjects without subjective gait impariment according to questionnaire answers.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Death at the time for the clinical evaluation.
65 Years
84 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Region Västerbotten
OTHER_GOV
Umeå University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jan Malm
MD, PhD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Norrlands Universitetssjukhus
Umeå, Västerbotten County, Sweden
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2017/335-31
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.